cagrilintide and semaglutide & GLP-1 S REDEFINE 1 Trial Finds Cagrilintide–Semaglutide

Talaei A, Siavash M, Majidi H, Chehrei A

Cagrilintide is a promising investigational peptide that has demonstrated favorable safety and tolerability profiles across multiple Phase 2 and Phase 3 clinical trials, including cardiac safety monitoring

Testing is especially critical for those on vegan or vegetarian diets, as plant-based foods lack natural B12

"Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance." Diabetologia

There are no conflicts of interest to disclose by the authors.

(Barbara Davis Center) presented on the psychosocial impact of T1D diagnoses (early-stage and clinical) on families